These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 16751806

  • 1. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland.
    Smith AP, Henze M, Lee JA, Osborn KG, Keck JM, Tedesco D, Bortner DM, Rosenberg MP, Reed SI.
    Oncogene; 2006 Nov 23; 25(55):7245-59. PubMed ID: 16751806
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX.
    Oncogene; 2001 Mar 22; 20(12):1445-54. PubMed ID: 11313888
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.
    Cancer Res; 2007 Aug 01; 67(15):7212-22. PubMed ID: 17671189
    [Abstract] [Full Text] [Related]

  • 4. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.
    Exp Mol Pathol; 2001 Jun 01; 70(3):183-93. PubMed ID: 11417997
    [Abstract] [Full Text] [Related]

  • 5. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
    Cui XS, Donehower LA.
    Oncogene; 2000 Dec 07; 19(52):5988-96. PubMed ID: 11146550
    [Abstract] [Full Text] [Related]

  • 6. A mouse model for cyclin E-dependent genetic instability and tumorigenesis.
    Loeb KR, Kostner H, Firpo E, Norwood T, D Tsuchiya K, Clurman BE, Roberts JM.
    Cancer Cell; 2005 Jul 07; 8(1):35-47. PubMed ID: 16023597
    [Abstract] [Full Text] [Related]

  • 7. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
    Brodie SG, Xu X, Qiao W, Li WM, Cao L, Deng CX.
    Oncogene; 2001 Nov 08; 20(51):7514-23. PubMed ID: 11709723
    [Abstract] [Full Text] [Related]

  • 8. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
    Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A.
    Nat Genet; 2001 Dec 08; 29(4):418-25. PubMed ID: 11694875
    [Abstract] [Full Text] [Related]

  • 9. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
    Ozbun MA, Jerry DJ, Kittrell FS, Medina D, Butel JS.
    Cancer Res; 1993 Apr 01; 53(7):1646-52. PubMed ID: 8453637
    [Abstract] [Full Text] [Related]

  • 10. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX.
    Nat Genet; 2001 Jul 01; 28(3):266-71. PubMed ID: 11431698
    [Abstract] [Full Text] [Related]

  • 11. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
    Ridgeway AG, McMenamin J, Leder P.
    Oncogene; 2006 Jun 15; 25(25):3518-27. PubMed ID: 16434961
    [Abstract] [Full Text] [Related]

  • 12. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
    Klein A, Guhl E, Tzeng YJ, Fuhrhop J, Levrero M, Graessmann M, Graessmann A.
    Oncogene; 2003 May 15; 22(19):2910-9. PubMed ID: 12771941
    [Abstract] [Full Text] [Related]

  • 13. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX.
    Nat Genet; 1999 May 15; 22(1):37-43. PubMed ID: 10319859
    [Abstract] [Full Text] [Related]

  • 14. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
    Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, Arnold A.
    Transgenic Res; 2001 Oct 15; 10(5):471-8. PubMed ID: 11708657
    [Abstract] [Full Text] [Related]

  • 15. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
    Liu S, Liu W, Jakubczak JL, Erexson GL, Tindall KR, Chan R, Muller WJ, Adhya S, Garges S, Merlino G.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3770-5. PubMed ID: 11867754
    [Abstract] [Full Text] [Related]

  • 16. Mutations in Apc and p53 synergize to promote mammary neoplasia.
    Méniel V, Hay T, Douglas-Jones A, Sansom OJ, Clarke AR.
    Cancer Res; 2005 Jan 15; 65(2):410-6. PubMed ID: 15695381
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ.
    Cancer Res; 2004 Aug 01; 64(15):5140-7. PubMed ID: 15289317
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A, McMenamin J, Zhou F, Moran JL, Beier DR, Leder P.
    Oncogene; 2008 Apr 10; 27(17):2456-65. PubMed ID: 17952114
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
    Rao NA, van Wolferen ME, Gracanin A, Bhatti SF, Krol M, Holstege FC, Mol JA.
    J Physiol Pharmacol; 2009 May 10; 60 Suppl 1():73-84. PubMed ID: 19609016
    [Abstract] [Full Text] [Related]

  • 20. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P.
    Eur J Cell Biol; 2007 Dec 10; 86(11-12):763-80. PubMed ID: 17198740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.